Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Lawrenceville, NJ
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Lawrenceville, NJ
Click here to add this to my saved trials
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Plainsboro, NJ
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Plainsboro, NJ
Click here to add this to my saved trials
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
New Hyde Park, NY
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Staten Island, NY
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Staten Island, NY
Click here to add this to my saved trials
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Syracuse, NY
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Syracuse, NY
Click here to add this to my saved trials
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Greensboro, NC
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Greensboro, NC
Click here to add this to my saved trials
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Dayton, OH
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Dayton, OH
Click here to add this to my saved trials
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Kettering, OH
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Kettering, OH
Click here to add this to my saved trials
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Clinton, OK
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Clinton, OK
Click here to add this to my saved trials
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Tulsa, OK
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Tulsa, OK
Click here to add this to my saved trials
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Eugene, OR
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Eugene, OR
Click here to add this to my saved trials
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Portland, OR
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Salem, OR
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Salem, OR
Click here to add this to my saved trials
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Lancaster, PA
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Lancaster, PA
Click here to add this to my saved trials
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Melrose Park, PA
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Melrose Park, PA
Click here to add this to my saved trials
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Norristown, PA
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Norristown, PA
Click here to add this to my saved trials
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
West Reading, PA
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
West Reading, PA
Click here to add this to my saved trials
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Greer, SC
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Greer, SC
Click here to add this to my saved trials
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Memphis, TN
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Memphis, TN
Click here to add this to my saved trials
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Arlington, TX
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Arlington, TX
Click here to add this to my saved trials
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Dallas, TX
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Houston, TX
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Lewisville, TX
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Lewisville, TX
Click here to add this to my saved trials
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Midland, TX
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Midland, TX
Click here to add this to my saved trials
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Plano, TX
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Plano, TX
Click here to add this to my saved trials
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
San Antonio, TX
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Ogden, UT
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Ogden, UT
Click here to add this to my saved trials
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Newport News, VA
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Newport News, VA
Click here to add this to my saved trials
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Richmond, VA
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Richmond, VA
Click here to add this to my saved trials
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Warrenton, VA
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Warrenton, VA
Click here to add this to my saved trials
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Bellevue, WA
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Bellevue, WA
Click here to add this to my saved trials
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Milwaukee, WI
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Manati,
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Manati,
Click here to add this to my saved trials
Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs
NovoLog® Mix 70/30 (Biphasic Insulin Aspart 70/30) Titrate-To-Target: An Observational Study of the Efficacy of NovoLog® Mix 70/30 in Patients With Type 2 Diabetes Mellitus Not Achieving Glycemic Targets on OADs With / Without Once Daily Basal Insulin Therapy
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Phoenix, AZ
Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs
NovoLog® Mix 70/30 (Biphasic Insulin Aspart 70/30) Titrate-To-Target: An Observational Study of the Efficacy of NovoLog® Mix 70/30 in Patients With Type 2 Diabetes Mellitus Not Achieving Glycemic Targets on OADs With / Without Once Daily Basal Insulin Therapy
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs
NovoLog® Mix 70/30 (Biphasic Insulin Aspart 70/30) Titrate-To-Target: An Observational Study of the Efficacy of NovoLog® Mix 70/30 in Patients With Type 2 Diabetes Mellitus Not Achieving Glycemic Targets on OADs With / Without Once Daily Basal Insulin Therapy
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
La Jolla, CA
Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs
NovoLog® Mix 70/30 (Biphasic Insulin Aspart 70/30) Titrate-To-Target: An Observational Study of the Efficacy of NovoLog® Mix 70/30 in Patients With Type 2 Diabetes Mellitus Not Achieving Glycemic Targets on OADs With / Without Once Daily Basal Insulin Therapy
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
La Jolla, CA
Click here to add this to my saved trials
Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs
NovoLog® Mix 70/30 (Biphasic Insulin Aspart 70/30) Titrate-To-Target: An Observational Study of the Efficacy of NovoLog® Mix 70/30 in Patients With Type 2 Diabetes Mellitus Not Achieving Glycemic Targets on OADs With / Without Once Daily Basal Insulin Therapy
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Deland, FL
Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs
NovoLog® Mix 70/30 (Biphasic Insulin Aspart 70/30) Titrate-To-Target: An Observational Study of the Efficacy of NovoLog® Mix 70/30 in Patients With Type 2 Diabetes Mellitus Not Achieving Glycemic Targets on OADs With / Without Once Daily Basal Insulin Therapy
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Deland, FL
Click here to add this to my saved trials
Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs
NovoLog® Mix 70/30 (Biphasic Insulin Aspart 70/30) Titrate-To-Target: An Observational Study of the Efficacy of NovoLog® Mix 70/30 in Patients With Type 2 Diabetes Mellitus Not Achieving Glycemic Targets on OADs With / Without Once Daily Basal Insulin Therapy
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Wichita, KA
Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs
NovoLog® Mix 70/30 (Biphasic Insulin Aspart 70/30) Titrate-To-Target: An Observational Study of the Efficacy of NovoLog® Mix 70/30 in Patients With Type 2 Diabetes Mellitus Not Achieving Glycemic Targets on OADs With / Without Once Daily Basal Insulin Therapy
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Wichita, KA
Click here to add this to my saved trials
Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs
NovoLog® Mix 70/30 (Biphasic Insulin Aspart 70/30) Titrate-To-Target: An Observational Study of the Efficacy of NovoLog® Mix 70/30 in Patients With Type 2 Diabetes Mellitus Not Achieving Glycemic Targets on OADs With / Without Once Daily Basal Insulin Therapy
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Omaha, NE
Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs
NovoLog® Mix 70/30 (Biphasic Insulin Aspart 70/30) Titrate-To-Target: An Observational Study of the Efficacy of NovoLog® Mix 70/30 in Patients With Type 2 Diabetes Mellitus Not Achieving Glycemic Targets on OADs With / Without Once Daily Basal Insulin Therapy
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Omaha, NE
Click here to add this to my saved trials
Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs
NovoLog® Mix 70/30 (Biphasic Insulin Aspart 70/30) Titrate-To-Target: An Observational Study of the Efficacy of NovoLog® Mix 70/30 in Patients With Type 2 Diabetes Mellitus Not Achieving Glycemic Targets on OADs With / Without Once Daily Basal Insulin Therapy
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Albany, NY
Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs
NovoLog® Mix 70/30 (Biphasic Insulin Aspart 70/30) Titrate-To-Target: An Observational Study of the Efficacy of NovoLog® Mix 70/30 in Patients With Type 2 Diabetes Mellitus Not Achieving Glycemic Targets on OADs With / Without Once Daily Basal Insulin Therapy
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Albany, NY
Click here to add this to my saved trials
Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs
NovoLog® Mix 70/30 (Biphasic Insulin Aspart 70/30) Titrate-To-Target: An Observational Study of the Efficacy of NovoLog® Mix 70/30 in Patients With Type 2 Diabetes Mellitus Not Achieving Glycemic Targets on OADs With / Without Once Daily Basal Insulin Therapy
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Cleveland, OH
Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs
NovoLog® Mix 70/30 (Biphasic Insulin Aspart 70/30) Titrate-To-Target: An Observational Study of the Efficacy of NovoLog® Mix 70/30 in Patients With Type 2 Diabetes Mellitus Not Achieving Glycemic Targets on OADs With / Without Once Daily Basal Insulin Therapy
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs
NovoLog® Mix 70/30 (Biphasic Insulin Aspart 70/30) Titrate-To-Target: An Observational Study of the Efficacy of NovoLog® Mix 70/30 in Patients With Type 2 Diabetes Mellitus Not Achieving Glycemic Targets on OADs With / Without Once Daily Basal Insulin Therapy
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Medford, OR
Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs
NovoLog® Mix 70/30 (Biphasic Insulin Aspart 70/30) Titrate-To-Target: An Observational Study of the Efficacy of NovoLog® Mix 70/30 in Patients With Type 2 Diabetes Mellitus Not Achieving Glycemic Targets on OADs With / Without Once Daily Basal Insulin Therapy
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Medford, OR
Click here to add this to my saved trials
Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs
NovoLog® Mix 70/30 (Biphasic Insulin Aspart 70/30) Titrate-To-Target: An Observational Study of the Efficacy of NovoLog® Mix 70/30 in Patients With Type 2 Diabetes Mellitus Not Achieving Glycemic Targets on OADs With / Without Once Daily Basal Insulin Therapy
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Memphis, TN
Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs
NovoLog® Mix 70/30 (Biphasic Insulin Aspart 70/30) Titrate-To-Target: An Observational Study of the Efficacy of NovoLog® Mix 70/30 in Patients With Type 2 Diabetes Mellitus Not Achieving Glycemic Targets on OADs With / Without Once Daily Basal Insulin Therapy
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Memphis, TN
Click here to add this to my saved trials
Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs
NovoLog® Mix 70/30 (Biphasic Insulin Aspart 70/30) Titrate-To-Target: An Observational Study of the Efficacy of NovoLog® Mix 70/30 in Patients With Type 2 Diabetes Mellitus Not Achieving Glycemic Targets on OADs With / Without Once Daily Basal Insulin Therapy
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Dallas, TX
Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs
NovoLog® Mix 70/30 (Biphasic Insulin Aspart 70/30) Titrate-To-Target: An Observational Study of the Efficacy of NovoLog® Mix 70/30 in Patients With Type 2 Diabetes Mellitus Not Achieving Glycemic Targets on OADs With / Without Once Daily Basal Insulin Therapy
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs
NovoLog® Mix 70/30 (Biphasic Insulin Aspart 70/30) Titrate-To-Target: An Observational Study of the Efficacy of NovoLog® Mix 70/30 in Patients With Type 2 Diabetes Mellitus Not Achieving Glycemic Targets on OADs With / Without Once Daily Basal Insulin Therapy
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Houston, TX
Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs
NovoLog® Mix 70/30 (Biphasic Insulin Aspart 70/30) Titrate-To-Target: An Observational Study of the Efficacy of NovoLog® Mix 70/30 in Patients With Type 2 Diabetes Mellitus Not Achieving Glycemic Targets on OADs With / Without Once Daily Basal Insulin Therapy
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs
NovoLog® Mix 70/30 (Biphasic Insulin Aspart 70/30) Titrate-To-Target: An Observational Study of the Efficacy of NovoLog® Mix 70/30 in Patients With Type 2 Diabetes Mellitus Not Achieving Glycemic Targets on OADs With / Without Once Daily Basal Insulin Therapy
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Ogden, UT
Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs
NovoLog® Mix 70/30 (Biphasic Insulin Aspart 70/30) Titrate-To-Target: An Observational Study of the Efficacy of NovoLog® Mix 70/30 in Patients With Type 2 Diabetes Mellitus Not Achieving Glycemic Targets on OADs With / Without Once Daily Basal Insulin Therapy
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Ogden, UT
Click here to add this to my saved trials
Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs
NovoLog® Mix 70/30 (Biphasic Insulin Aspart 70/30) Titrate-To-Target: An Observational Study of the Efficacy of NovoLog® Mix 70/30 in Patients With Type 2 Diabetes Mellitus Not Achieving Glycemic Targets on OADs With / Without Once Daily Basal Insulin Therapy
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Renton, WA
Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs
NovoLog® Mix 70/30 (Biphasic Insulin Aspart 70/30) Titrate-To-Target: An Observational Study of the Efficacy of NovoLog® Mix 70/30 in Patients With Type 2 Diabetes Mellitus Not Achieving Glycemic Targets on OADs With / Without Once Daily Basal Insulin Therapy
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Renton, WA
Click here to add this to my saved trials
Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs
NovoLog® Mix 70/30 (Biphasic Insulin Aspart 70/30) Titrate-To-Target: An Observational Study of the Efficacy of NovoLog® Mix 70/30 in Patients With Type 2 Diabetes Mellitus Not Achieving Glycemic Targets on OADs With / Without Once Daily Basal Insulin Therapy
Status: Enrolling
Updated:  1/10/2017
Novo Nordisk Investigational Site
mi
from
Milwaukee, WI
Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs
NovoLog® Mix 70/30 (Biphasic Insulin Aspart 70/30) Titrate-To-Target: An Observational Study of the Efficacy of NovoLog® Mix 70/30 in Patients With Type 2 Diabetes Mellitus Not Achieving Glycemic Targets on OADs With / Without Once Daily Basal Insulin Therapy
Status: Enrolling
Updated: 1/10/2017
Novo Nordisk Investigational Site
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans
Status: Enrolling
Updated:  1/11/2017
Massachusetts General Hospital
mi
from
Boston, MA
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans
Status: Enrolling
Updated: 1/11/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans
Status: Enrolling
Updated:  1/11/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans
Status: Enrolling
Updated: 1/11/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans
Status: Enrolling
Updated:  1/11/2017
Joslin Diabetes Center
mi
from
Boston, MA
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans
Status: Enrolling
Updated: 1/11/2017
Joslin Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials